• SENSEX
    NIFTY 50
Business

AstraZeneca bets up to $6 billion on new Daiichi cancer drug

Updated : July 27, 2020 03:07 PM IST

The company and Daiichi had signed a near USD 7 billion deal in 2019 for an ADC targeting the HER2 protein typical of some breast cancers, to challenge the world's biggest cancer drug maker Roche
AstraZeneca and Daiichi have also been in talks over the supply of the British company's potential coronavirus vaccine in Japan.
AstraZeneca bets up to $6 billion on new Daiichi cancer drug

You May Also Like

Live TV
Advertisement